Teladoc Health (NYSE:TDOC)‘s stock had its “hold” rating restated by equities research analysts at SunTrust Banks in a report issued on Monday, MarketBeat reports. They presently have a $80.00 price objective on the health services provider’s stock. SunTrust Banks’ price objective suggests a potential upside of 1.42% from the company’s current price.

Other equities analysts have also issued reports about the company. Royal Bank of Canada started coverage on Teladoc Health in a research note on Wednesday, November 27th. They issued an “outperform” rating and a $100.00 price objective on the stock. JPMorgan Chase & Co. increased their target price on shares of Teladoc Health from $82.00 to $83.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Zacks Investment Research lowered shares of Teladoc Health from a “buy” rating to a “hold” rating and set a $89.00 price target on the stock. in a report on Wednesday, November 27th. Stifel Nicolaus assumed coverage on shares of Teladoc Health in a research report on Monday, November 25th. They set a “hold” rating and a $83.00 price target on the stock. Finally, Piper Jaffray Companies set a $87.00 price objective on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, August 16th. Four research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Teladoc Health has an average rating of “Buy” and an average price target of $81.73.

Shares of Teladoc Health stock opened at $78.88 on Monday. Teladoc Health has a twelve month low of $42.08 and a twelve month high of $86.30. The stock has a market capitalization of $5.71 billion, a P/E ratio of -54.78 and a beta of 1.40. The company has a current ratio of 6.55, a quick ratio of 6.55 and a debt-to-equity ratio of 0.44. The business’s fifty day moving average price is $76.85 and its 200 day moving average price is $67.27.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.40) by $0.12. The firm had revenue of $137.96 million during the quarter, compared to the consensus estimate of $136.46 million. Teladoc Health had a negative return on equity of 11.23% and a negative net margin of 20.15%. The firm’s quarterly revenue was up 24.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.34) earnings per share. As a group, sell-side analysts predict that Teladoc Health will post -1.55 EPS for the current year.

In related news, SVP Andrew Turitz sold 9,158 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $62.27, for a total transaction of $570,268.66. Following the transaction, the senior vice president now directly owns 6,827 shares of the company’s stock, valued at approximately $425,117.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Lewis Levy sold 675 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $70.00, for a total value of $47,250.00. Following the completion of the transaction, the insider now owns 4,805 shares of the company’s stock, valued at approximately $336,350. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 75,907 shares of company stock worth $5,574,483. Company insiders own 3.14% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Westside Investment Management Inc. purchased a new position in shares of Teladoc Health in the second quarter valued at $26,000. CNB Bank lifted its holdings in Teladoc Health by 100.0% in the 3rd quarter. CNB Bank now owns 400 shares of the health services provider’s stock worth $27,000 after buying an additional 200 shares in the last quarter. Capital Investment Advisory Services LLC lifted its holdings in Teladoc Health by 800.0% in the 3rd quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock worth $30,000 after buying an additional 400 shares in the last quarter. Tradewinds Capital Management LLC boosted its position in Teladoc Health by 186.0% in the 2nd quarter. Tradewinds Capital Management LLC now owns 615 shares of the health services provider’s stock valued at $41,000 after buying an additional 400 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its position in Teladoc Health by 32.4% in the 3rd quarter. Quadrant Capital Group LLC now owns 621 shares of the health services provider’s stock valued at $41,000 after buying an additional 152 shares during the last quarter.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: What does an equal weight rating mean?

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.